Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children.
Green H, Gibb DM, Walker AS, Pillay D, Butler K, Candeias F, Castelli-Gattinara G, Compagnucci A, Della Negra M, de Rossi A, Feiterna-Sperling C, Giaquinto C, Harper L, Levy J, Saidi Y, Wintergerst U; Paediatric European Network for the Treatment of AIDS (PENTA).
Green H, et al. Among authors: saidi y.
AIDS. 2007 May 11;21(8):947-55. doi: 10.1097/QAD.0b013e3280e087e7.
AIDS. 2007.
PMID: 17457088
Clinical Trial.